Is there an approved version of what you were going to buy?
Pick a gray-market peptide, or the goal you were buying it for, and see the FDA-approved medicines for that goal. Each option quotes who its label says it is for, shows any boxed warning, and links to the full label on DailyMed with its version and date. Approval covers a specific product for specific people; this page cannot tell you whether one is right for you. Take it to a clinician. We name no sellers and no prices.
9 goals, 17 gray-market peptides, 19 approved options; labels read 2026-09-30 to 2026-10-03. Not medical advice: see a doctor before starting, stopping or changing any medicine. Related: the Legal Status Checker, the Stack Safety Analyzer and what research use only means.
What the finder does
Most gray-market peptides are bought for a reason: losing weight, raising growth hormone, libido, tanning, smoother skin, a better gut. For many of those goals, an FDA-approved medicine already exists, sometimes the very same molecule. The finder covers 9 goals and 19 approved options. Pick a peptide you have seen sold, or the goal itself, and it shows what is approved for that goal and for whom.
Each option quotes a phrase from the INDICATIONS AND USAGE section of its current US label, shows the label's boxed warning if it has one, and links to the full label on DailyMed with the version and effective date we read. The evidence grade next to each name is the one on our encyclopedia entry for that compound.
Why an approved option is different
An approved medicine is a specific product made to a checked standard, with a dose, a label and a safety record that the regulator reviewed. A vial sold for 'research use only', even with the same name, is none of those things: its content and purity are unverified and nobody has reviewed its use in people. Our article on what research use only means explains the gap.
Two of the options here are the gray-market molecule itself in approved form. Bremelanotide is sold online as PT-141 and approved as Vyleesi for a defined group of premenopausal women. Tesamorelin is sold as a research peptide for belly fat and approved as Egrifta WR only for excess abdominal fat in adults with HIV lipodystrophy; its label says it is not for weight loss.
What it cannot tell you
An approval covers the people and conditions on the label. Many of the options are approved only for narrow groups: growth hormone for confirmed deficiency, setmelanotide for specific genetic and hypothalamic obesity, afamelanotide for a rare light-sensitivity disorder. For some goals, such as cosmetic tanning or general 'gut healing', nothing is approved, and the finder says so rather than stretching a label to fit.
It does not tell you whether a medicine is right for you, how much it costs or where to get it. We do not list pharmacies, telehealth sellers or prices. Use the questions under each goal with a doctor, and check the full label for contraindications and interactions; our Stack Safety Analyzer shows recorded interactions between compounds.
How the page checks itself
The page will not build if any quoted indication is missing from its label, if a label lacks its DailyMed set id or was read too long ago, or if the page links anywhere other than DailyMed, the FDA or this site. Those rules are tested against deliberately broken data each time the site is built. Labels change; the version and date on each card tell you which one we read.
Sources
This explainer describes how the tool works and what its numbers rest on. It is not medical advice and does not recommend any dose or product.